NEW YORK (TheStreet) -- Shares of Accuray were falling 14% to $6.23 Thursday after the medical appliance and equipment company missed analysts' estimates for earnings and revenue in the fiscal first quarter. Accuray reported a loss of 28 cents a share for the fiscal first quarter, below the loss of 13 cents a share analysts' surveyed by Zacks Investment Research expected for the quarter. Revenue grew 7.5% year over year to $82.38 million, missing analysts' estimates of $87.3 million for the quarter. The company said it expects full-year revenue of $390 million to $410 million. Must Read:aWarren Buffett's 25 Favorite Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. "While we are not giving orders guidance, we expect order growth to improve as the year progresses and on a full year-over-year comparison we expect to be at a substantially higher growth rate than the overall market," president and CEO Joshua H. Levine said in a statement. TheStreet Ratings team rates ACCURAY INC as a Hold with a ratings score of C-. TheStreet Ratings Team has this to say about their recommendation: "We rate ACCURAY INC (ARAY) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk." You can view the full analysis from the report here: ARAY Ratings Report ARAY data by YCharts STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Click to view a price quote on ARAY. Click to research the Health Services industry.
from Latest TSC Headlines http://ift.tt/1zNqfy5
No comments:
Post a Comment